1 July 2022
ANANDA DEVELOPMENTS PLC
(“Ananda” or the “Company”)
TOTAL VOTING
RIGHTS
In accordance with the Financial Conduct Authority's Disclosure
and Transparency Rules, Ananda announces that the Company has
820,554,572 ordinary shares of 0.2p each in issue (“Ordinary
Shares“), each share carrying the right to one vote.
This figure of 820,554,572 Ordinary Shares may be used by
shareholders in the Company as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change to their interest in, the share capital of
the Company under the FCA's Disclosure and Transparency
Rules.
-Ends-
The Directors of the Company accept responsibility for the
contents of this announcement.
ANANDA DEVELOPMENTS PLC
Chief Executive Officer
Melissa Sturgess
Investor Relations
Jeremy Sturgess-Smith |
+44 (0) 7463 686
497
ir@anandadevelopments.com |
PETERHOUSE CAPITAL LIMITED
Corporate Finance
Mark Anwyl
Corporate Broking
Lucy Williams
Duncan Vasey |
+44 (0)20 7469
0930 |
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by
the Company to constitute inside information. Upon the publication
of this announcement via a Regulatory Information Service, this
inside information is now considered to be in the public
domain.
About Ananda Developments
Ananda is an AQSE-listed medical cannabis company creating
UK-based operations to grow and provide carbon zero, consistent,
medical cannabis for the UK and international markets.
The UK medical cannabis market is predicted to be worth £450m by
2025 and the European market is predicted to be worth USD4.2bn by 2027.
For more information, please
visit: https://anandadevelopments.com/
